Skip to main content

Table 2 Health status and behaviour variables (N = 300)

From: Non-adherence to anti-retroviral therapy among HIV infected adults in Mon State of Myanmar

Variables

Number

Percent

Duration on ART

Mean ± SD: 4.3 ± 2.1

  < 1 year

25

8.3

 1-3 year

147

49.0

  > 3 year

128

42.7

Recent CD4 (cells/mm3)

Mean ± SD: 517.5 ± 263.3

  < 500

158

52.7

 500-1000

122

40.7

  > 1000

20

6.7

HIV medication

 ART first line drugs

277

92.3

 ART second line drugs

23

7.7

ART Regimen

 TDF/ABC + 3TC + EFV (one time/day)

171

57.0

 AZT/ABC + 3TC + NVP/LPV/r (2 times/day)

129

43.0

Co-morbid diseases

 Absence of co-morbidity

248

82.7

 Presence of co-morbidity

52

17.3

 Past month alcohol use

50

16.7

 Smokes tobacco daily

27

9.0

 Smokeless tobacco use daily

37

12.3

 Disclosure of HIV status to others

241

80.3

 Moderate to severe depressive symptoms

23

7.7

Internalized stigma (Range:0-7)

Mean ± SD

2.7 ± 2.3

 No stigmatization

67

22.3

 Low stigmatization

132

44.0

 High stigmatization

101

33.7

Social support (Range 3-12)

Mean ± SD

9.7 ± 2.0

 Less

194

64.7

 High

106

35.3

Sex functioning among male respondent (n = 107) (Range 5-25)

Mean ± SD: 18.9 ± 2.7

 No erectile dysfunction (ED)

49

45.8

 Mild ED

44

41.1

 Mild to moderate ED

14

13.1

  1. TDF Tenofovir, ABC Abacavir, 3TC Lamivudine, EFV Efavirenz, AZT Zidovudine, NVP Nevirapine, LPV/r Lopinavir/ritonavir, SD standard deviation